Focus Stocks
Sanofi-Aventis Is Close to Resistance
Published on Thursday, 21 February 2013 08:00 Written by TradersHuddle Wire
New York, February 21st (TradersHuddle.com) - Shares of Sanofi-Aventis (NYSE:SNY) are trading very close to calculated resistance at $49.53. The stock ended the trading session at just $48.85, which is near levels that make it difficult to buy or start a position.
Sanofi-Aventis (NYSE:SNY) is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
Sanofi-Aventis' stock range is defined by its calculated support defined at $44.50 and by the resistance level at $49.53; the stock is clearly over-extended from support, making it harder for participants to establish fresh longs.
Traders don't have a clear entry point for Sanofi-Aventis . However, as the stock pulls back towards $44.50 it will definitely provide a reference point to establish a trade. On the other hand, if the stock breaks above its resistance level at $49.53 then traders will get an opportunity to enter the stock as it moves to a higher range.
Related Articles
- Critical Alerts For Sanofi, Salesforce.com, AFLAC, HCA Holdings, and Silver Wheaton Released By InvestorsObserver
- Sanofi-Aventis Is Close to the 50 Day Moving Average
- Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
- Approaching Resistance: Sanofi-Aventis
- Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
- Reference Points for Sanofi-Aventis
- Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
- Approaching Resistance: Sanofi-Aventis
- Sanofi-Aventis Is Close to Resistance
Related Partner Headlines
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi (SNY): Today's Featured Drugs Laggard - TheStreet.com
- Zalicus Prednisporin Licensee Sanofi Provides Update on Development Status - Benzinga
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi Reaches New 52-Week High (SNY) - TheStreet.com
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi To Buy Genfar - Benzinga
- Sanofi Stock Buy Recommendation Reiterated (SNY) - TheStreet.com
- Sanofi (SNY): Today's Featured Health Care Laggard - TheStreet.com
- Sanofi Reaches New 52-Week High (SNY) - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
-
Chesapeake Energy Is Close to Resistance -
Windstream Is Near its 50 Day Moving Average -
Applied Materials Is Close to Resistance -
E*TRADE is Near a Key Support Area -
First Solar is Near a Key Support Area -
Trading Idea: Is Monster Worldwide close to Support? -
Trading Idea: - Is Walgreen close to Resistance?
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,303.10 Trade time:4:36PM EDT Value change:▲8.60 (0.06%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,649.60 Trade time:4:35PM EDT Value change:▼0.91 (-0.06%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,459.14 Trade time:5:15PM EDT Value change:▼0.28 (-0.01%)In The Wires
-
ATK Technologies Support Launch of ULA's Delta IV Rocket Carrying WGS-5 -
What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples -
Zamansky & Associates LLC Files FINRA Arbitration for Investors Against Investors Capital Corporation -
Delaware E-Records First Document Through Simplifile -
The Cash Store Financial Services Inc. Files Amended Financial Statements -
As Summer Quickly Approaches, Car Rental Express (CRX) Suggests Some Great California Wineries to Visit -
Adapt or Die: Web Business Owner James Schramko Shares Critical Strategy on Business Growth -
Seven Arts Entertainment Inc. Responds To Defamatory And Fraudulent Claim








